Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Net Margin (2023 - 2026)

Updated

Mereo BioPharma's Net Margin came in at -8375.60% for FY2025.

Analysis

Mereo BioPharma (MREO) Net Margin (2023 - 2026) Analysis & Trends

  • Net Margin carries a four-year change of -8410.50 percentage points (FY2021 to FY2025).
  • Per Business Quant, earlier years put Net Margin at -294.66% in FY2023 and 34.90% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Mereo BioPharma 46.45 Mn -103.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -61,081.82%
Jun 30, 2025 -2,923.20%
Dec 31, 2023 -910.90%
Jun 30, 2023 -19.46%
API Access

Mereo BioPharma Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=MREO&period=max&api_key=YOUR_API_KEY